|
Showing 1 - 25 of
644 matches in All Departments
"Damn Good Advice (For People With Talent )" is a look into the
mind of one of America's most legendary creative thinkers, George
Lois. Offering indispensle lessons, practical advice, facts,
anecdotes and inspiration, this book is a timeless creative bible
for all those looking to succeed in life, business and creativity.
These are key lessons derived from the incomparle life of 'Master
Communicator' George Lois, the original Mad Man of Madison Avenue.
Written and compiled by the man "The Wall Street Journal" called
"prodigy, enfant terrible, founder of agencies, creator of
legends," each step is borne from a passion to succeed and a
disdain for the status quo.
Organised into inspirational, bite-sized pointers, each page offers
fresh insight into the sources of success, from identifying your
heroes to identifying yourself. The ideas, images and illustrations
presented in this book are fresh, witty and in-your-face. Whether
it's communicating your point in nanosecond, creating an explosive
portfolio or making your presence felt, no one is better placed
than George Lois to teach you the process of creativity.
Poignant, punchy and to-the-point, "Damn Good Advice (For People
With Talent )" is a must have for anyone on a quest for success.
|
JEAN-PAUL GOUDE (Paperback)
Jean-Paul Goude, George Lois, Jean Paul Gaultier, Eric Troncy, Jerome Sans
|
R1,008
Discovery Miles 10 080
|
Ships in 12 - 17 working days
|
Jean-Paul Goude is a modern legend in the world of commercial art.
From his New York days with Esquire magazine to his latest work for
Galeries Lafayette, he has consistently provoked and delighted
those who have encountered his work. He was Grace Jones's
Pygmalion, creating unforgettable images of her, from androgyne to
cyber-superwoman to supreme diva. This volume, published to
accompany a major retrospective at the Musee des Arts Decoratifs in
Paris, is a celebration of his creative zest and perfectionism, and
his unique affinity for making fresh and engaging work. Around 600
images are on show, including many working documents published here
for the first time, from inspired doodles to final images that
sparkle with creative vigour. Selected and arranged by Goude
himself, they present a gallery of artworks that have redefined
advertising and brand photography as we know them. Sexy, irreverent
and full of humour, this book will inform and instruct all those
concerned with the art of image-making, whether professionals or
simply those prepared to be entertained by chic, witty images that
work.
George Lois is an American icon in graphic design. This book
showcases his logos with his own comments on why they work. A bonus
in the book is a chapter of world logos made by others with George
Lois's comments on why they are so good. George Lois continues to
prove that a memorable brand name interacting with a strong visual
symbol to communicate a humanistic idea is the ultimate art form in
popular graphic communication. His Big Idea branding and logo
design, developed with a built-in, conceptual, "catchy" brand name,
can visually impart information in a nanosecond, delivering a
specific ethos with a penetrating promise of power that immediately
sears a product's virtues into a viewers' brain-and has the
potential of bringing instantaneous success. Lois boldly states,
"My goal, with the vast majority of the brands I have named and
logos I have designed, is to create 'humanistic' symbols, driven by
a pregnant idea, visualizing some recognizable aspect of the human
experience, and magically relating it to a unique selling
proposition that empowers great advertising and promotion." If
anyone wants to experience the creation of Big Idea Branding, this
astounding compilation of the work of George Lois is the ultimate
form of clear, precise, eye-popping communication.
"Precision/personalized or stratified medicine" refers to the
tailoring of medical treatment or drug administration to the
individual characteristics of each patient treatment. It does not
literally mean that a pharmaceutical company makes a drug for an
individual patient for consumption and treatment but rather means
the ability to stratify (or classify) individuals into
sub-populations that differ in their responsiveness to a specific
drug. A marker that provides information on the likely response to
therapy, i.e., either in terms of tumor shrinkage or survival of
the patient is termed "predictive biomarker". Despite their promise
in precision medicine and the explosion of knowledge in this area,
there is not a single source on this subject that puts all this
evidence together in a concise or richly illustrated and easy to
understand manner. This book provides a collection of ingeniously
organized, well-illustrated and up-to-date authoritative chapters
divided into five sections that are clear and easy to understand.
Section one provides an overview of biomarkers, introduces the
basic terminologies, definitions, technologies, tools and concepts
associated with this subject in the form of illustrations/graphics,
photographs and concise texts. Several recent biomarker endeavors
that have been initiated and funded by the National Cancer
Institute, National Institutes of Health, FDA and other
International organizations are presented. Section two involves the
signaling pathways controlling cell growth and differentiation
altered in cancer. This section analyzes how predictive biomarkers
are altered (expressed or amplified) across cancer types. Section
three explores how predictive biomarkers play a role in patient
stratification and tailored treatment in relationship to specific
cancers. In addition, it includes discussion on the various
precision medicine initiatives that are going on across the globe
(e.g. TARGET, NCI-MATCH, BATTLE, SHIVA, etc.). Section four
discusses: (a) how pharmaceutical companies validate predictive
biomarker assays and accompanying companion diagnostics either
internally or externally with partner companies such as central
laboratories or clinical research organizations, and (b) how
predictive biomarker tests fall under the oversight of US FDA,
Centers for Medicare & Medicaid Services (CMS) and state laws.
Section five wraps up novel agents and targets that are being used
as targets for cancer therapeutics. The biomarkers associated with
these protocols will also be presented. Throughout the book,
sidebars, special interest boxes and illustrations are used to
explain terms that are either newly introduced, uncommon, or
specialized. Predictive Biomarkers in Oncology will serve as a
definitive guide for practicing pathologists, oncologists, basic
researchers, and personnel in the pharmaceutical or diagnostic
industry interested in learning how "predictive biomarkers" are
used in precision cancer therapy.
|
You may like...
Loot
Nadine Gordimer
Paperback
(2)
R398
R330
Discovery Miles 3 300
|